STOCK TITAN

Edesa Biotech (EDSA) joint filing reports 5.4% stake by Millennium group

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Edesa Biotech, Inc. Schedule 13G shows a group of related filers including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander reporting shared beneficial ownership of 520,685 shares, equal to 5.4% of the company’s common stock. The filing bases the percent on 9,621,192 Common Shares outstanding, composed of 8,891,951 shares as of May 13, 2026 and 729,241 shares issued in a private placement that closed on or about June 15, 2026. The filing is a joint filing under a Joint Filing Agreement dated June 17, 2026 and describes shared voting and dispositive power rather than sole control.

Positive

  • None.

Negative

  • None.

Insights

Joint filing reports a 5.4% shared stake via related Millennium entities.

The schedule lists 520,685 shares (5.4%) reported as shared voting and dispositive power among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. The percentage uses an outstanding share base of 9,621,192 shares.

Ownership is presented as held by entities subject to manager/trustee control; the filing clarifies this structure and includes a Joint Filing Agreement. Future disclosure of any changes would appear in subsequent ownership filings.

Position size and timing are explicitly tied to a recent private placement.

The calculation cites 8,891,951 shares outstanding as of May 13, 2026 plus 729,241 shares from a private placement that closed on or about June 15, 2026, producing a 9,621,192-share base. The filing therefore reflects post-placement ownership math.

Cash‑flow treatment and any planned dispositions are not detailed in the excerpt; subsequent Section 13 filings would report transaction direction or changes in holdings.

Reported shares 520,685 shares shared beneficial ownership reported on Schedule 13G
Percent of class 5.4% calculated percent of common stock
Shares outstanding (basis) 9,621,192 shares sum of outstanding as of <date> and private placement (basis for percent)
Shares outstanding as of May 13, 2026 8,891,951 shares reported in issuer's Form 10-Q filed May 14, 2026
Private placement shares 729,241 shares issued in private placement closed on or about June 15, 2026
Schedule 13G regulatory
"Schedule 13G shows a group of related filers including Integrated Core Strategies"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: See response to Item 9 on each cover page"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Joint Filing Agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of June 17, 2026"
shared dispositive power financial
"Shared Dispositive Power 520,685.00 on each cover page"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Millennium report in EDSA?

The filing reports 520,685 shares, equal to 5.4% of common stock. This percentage is calculated using 9,621,192 shares outstanding after a private placement closed on or about June 15, 2026.

Which entities joined the joint filing for Edesa Biotech (EDSA)?

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander executed a Joint Filing Agreement dated June 17, 2026 and filed the Schedule 13G together.

How did the filing calculate percent ownership for EDSA?

Percent ownership used a base of 9,621,192 Common Shares outstanding, derived from 8,891,951 shares as of May 13, 2026 plus 729,241 shares issued in a private placement closing on or about June 15, 2026.

Does the Schedule 13G show sole control of the reported shares?

No. The filing shows shared voting and dispositive power over the 520,685 shares, with zeros for sole voting and sole dispositive power on the cover pages.

When was the joint filing signed for Edesa Biotech (EDSA)?

The Joint Filing Agreement and the signatures on the Schedule 13G are dated June 17, 2026, as shown on the exhibit and cover-page signings.





27966L306

(CUSIP Number)
06/11/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/17/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/17/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/17/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:06/17/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 17, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.